MassDevice.com +5 | The top 5 medtech stories for August 18, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. HeartWare recalls some HVAD implantable heart pumps on electrical fault risk HeartWare International this week recalled some of its HVAD implantable heart pumps on the risk of electrical faults from driveline contamination. The recall affects an unspecified number of the left ventricular assist devices, according to an August 15 letter the Framingham, Mass.-based company sent to physicians who implant the pump. Connector contamination of the driveline most often occurred in the 1st 30 days, according to HeartWare, which agreed in June to a $1.1 billion acquisition by Medtronic. Read more 4. Spectral Medical eyes final PMA bid by year-end for Toraymyxin anti-sepsis device Spectral Medical said today that it plans to file its final pre-market approval module with the FDA for its sepsis treatment by the end of the year, after the impending release of primary endpoint data from a clinical trial. The Toronto-based company developed a stand-alone pump, the Toraymyxin device, designed for use with an assay to identify endotoxin levels. The system aims to use hemoperfusion to remove sep...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news